Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.

Hepatology (Baltimore, Md.) - 1 Sept 2010

Harrison Stephen A, Rossaro Lorenzo, Hu Ke-Qin, Patel Keyur, Tillmann Hans, Dhaliwal Sandeep, Torres Dawn M, Koury Kenneth, Goteti Venkata S, Noviello Stephanie, Brass Clifford A, Albrecht Janice K, McHutchison John G, Sulkowski Mark S

Abstract excerpt

UNLABELLED: Elevated low-density lipoprotein (LDL) levels and statin use have been associated with higher sustained virological response (SVR) rates in patients receiving chronic hepatitis C therapy. However, these relationships have not been well characterized in randomized controlled trials. Furthermore, little is known about the relationship between high-density lipoprotein (HDL) and virological response. To...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, HDL
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Regression Analysis

Share to Ribavirin

Source

Identifiers

PMID: 20568303
DOI: 10.1002/hep.23787

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.PMID 20568303Read ↗

Associations between serum lipids and hepatitis C antiviral treatment efficacy.Semantic proximity Read ↗

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.Semantic proximity Read ↗

Sustained virologic response and other potential genotype-specific roles of statins among patients with hepatitis C-related chronic liver diseases.Semantic proximity Read ↗

Association of low-density lipoprotein receptor genotypes with hepatitis C viral load.Semantic proximity Read ↗

Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.Semantic proximity Read ↗

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study.Semantic proximity Read ↗

The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis.Semantic proximity Read ↗

An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin.Semantic proximity Read ↗

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment.Semantic proximity Read ↗

Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis.Semantic proximity Read ↗

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.Semantic proximity Read ↗

Brief Report: Differential Timing of Cholesterol Increase During Successful HCV Therapy: Impact of Type of Drug Combination.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.